The glucocorticoid receptor gene polymorphism N363S predisposes to more severe toxic side effects during pediatric acute lymphoblastic leukemia (ALL) therapy-Reference-Cited by-同舟云学术

The glucocorticoid receptor gene polymorphism N363S predisposes to more severe toxic side effects during pediatric acute lymphoblastic leukemia (ALL) therapy

Published:2013-01-26 Issue:2 Volume:97 Page:216-222
ISSN:0925-5710
Container-title:International Journal of Hematology
language:en
Short-container-title:Int J Hematol

Author:

Eipel O. T.,Németh K.,Török D.,Csordás K.,Hegyi M.,Ponyi A.,Ferenczy A.,Erdélyi D. J.,Csóka M.,Kovács G. T.

Publisher

Springer Science and Business Media LLC

Subject

Hematology

Link

http://link.springer.com/content/pdf/10.1007/s12185-012-1236-1.pdf

Reference53 articles.

1. Schiffman JD, Wang Y. McPherson, et al. Molecular inversion probes reveal patterns of 9p21 deletion and copy number aberrations in childhood leukemia. Cancer Genet Cytogenet. 2009;193:9–18.

2. Lee-Sherick AB, Linger RM, Gore L, et al. Targeting paediatric acute lymphoblastic leukaemia: novel therapies currently in development. Br J Haematol. 2010;151:295–311.

3. Mussai F, Campana D, Bhojwani D, et al. Cytotoxicity of the anti-CD22 immunotoxin HA22 (CAT-8015) against paediatric acute lymphoblastic leukaemia. Br J Haematol. 2010;150:352–8.

4. Stanulla M, Schrauder A. Bridging the gap between the north and south of the world: the case of treatment response in childhood acute lymphoblastic leukemia. Haematol Hematol J. 2009;94:748–52.

5. Tissing WJE, Meijerink JPP, den Boer ML, et al. Genetic variations in the glucocorticoid receptor gene are not related to glucocorticoid resistance in childhood acute lymphoblastic leukemia. Clin Cancer Res. 2005;11:6050–6.

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How I treat long-term survivors of childhood acute leukemia;Blood;2024-05-02

2. Novel Aspects of Leukemia Pharmacogenomics;Leukemia;2022-10-16

3. Pharmacogenomics and Pharmacotranscriptomics of Glucocorticoids in Pediatric Acute Lymphoblastic Leukemia;Corticosteroids - A Paradigmatic Drug Class;2021-11-24

4. Long-Term Effects of Pediatric Acute Lymphoblastic Leukemia Chemotherapy: Can Recent Findings Inform Old Strategies?;Frontiers in Oncology;2021-10-15

5. Risk factors for steroid‐induced adverse psychological reactions and sleep problems in pediatric acute lymphoblastic leukemia: A systematic review;Psycho-Oncology;2021-04-06